the market?
MannKind Corp
NASDAQ: MNKD
7.12
0.51
(7.72%)
| Today's Open | $6.78 |
|---|---|
| Previous Close | $6.61 |
| Daily Range | $6.65 - $7.25 |
| 52-Week Range | $1.79 - $8.06 |
| Market Cap | $2.1B |
| P/E Ratio | -8.05 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 7,020,862 |
| Average Daily Volume | 10,317,580 |
| Current FY EPS | -$0.49 |
How do you think MNKD
will perform against the market?
Top MNKD Bull/Bear Pitches
zzlangerhans (< 20)
Submitted
January 27, 2011
So ... tired ... of ... talking ... about ... MannKind ... There's still lots of KoolAid left in the jug.
zzlangerhans (< 20)
Submitted
December 22, 2010
There's no point in going over what's been argued a million times. At this price level, I see more downside in the short-term regardless of the PDUFA outcome. I think another technical CRL is the most … More
News & Commentary
The Dow's Triple-Digit Gains Left These Stocks Behind
The stock market posted a sixth straight day of 100-point moves, with today's being to the upside.Why MannKind Is Poised to Pull Back
Market-lagging returns could be written in this 2-star stock.White Collar Criminals Love Biotech Stocks
It's easy to see why.MannKind Still Treading Water, So Why Are Investors Surfing?
MannKind is treading water waiting for Afrezza results, but investors are surfing on the stock's rise. Is a wipeout or an epic wave on the way?3 Reasons You Shouldn't Buy Stocks in Biotech
Wondering if you should buy stocks in biotech? Here are 3 reasons why you might want to take a pass.Sector
Healthcare
Industry
Drugs
MannKind Corp (MNKD) Description
A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website: http://www.mannkindcorp.com/
CEO Rating by Glassdoor
More details for MannKind Jobs
MannKind reviews from employees
